 |
 |
 |
 |
 |
 |
The SGC has, in collaboration with pharma and academic partners, generated a number of probes for epigenetic targets. Whilst work in this area is continuing the SGC, again in collaboration with pharma and academic partners, is now extending the target focus beyond epigenetics to targets from a range of other protein classes. These probes will continue to meet the high criteria of potency and selectivity established for the epigenetics probes and will be made available to help elucidate the biological and therapeutic function of the target proteins.
